New Neurological Findings and Documentation System Developed at Göttingen University

MEDNOVO Medical Software Solutions GmbHAn innovative neurological findings and documentation system named "NEMESYS" has been developed in the Department of Clinical Neurophysiology at Göttingen University School of Medicine. As regards content NEMESYS was developed in the Department of Clinical Neurophysiology at the University Hospital Göttingen (UKG) by Professor (Prof. Dr.) W. Paulus, Director of the Department of Clinical Neurophysiology, and private lecturer (Priv. Doz. Dr. med.) F. Tergau, St. Bernward Hospital in Hildesheim, formerly Department of Clinical Neurophysiology of the UKG. Technically NEMESYS was developed by Dipl. Phys. J. Lessing (Faculty of Physics).

From the left: Dipl.-Ing. Markus Mladek (MBM), Michael Heinlein (Managing Director  MEDNOVO Medical Software Solutions GmbH), Dr. Hans-Joachim Conrad (Executive Board of Management and Administration of the Göttingen University School of Medicine), Prof. Dr. Walter Paulus (Director of the Department of Clinical Neurophysiology)
From the left (Photo: umg): Dipl.-Ing. Markus Mladek (MBM), Michael Heinlein (Managing Director MEDNOVO Medical Software Solutions GmbH), Dr. Hans-Joachim Conrad (Executive Board of Management and Administration of the Göttingen University School of Medicine), Prof. Dr. Walter Paulus (Director of the Department of Clinical Neurophysiology).

MBM ScienceBridge GmbH, the technology transfer organization of Göttingen University, has been able to win the company MEDNOVO Medical software Solutions GmbH from Berlin as a licence partner for NEMESYS. "This partnership of science and economy again is a good example how our inhouse innovations are financially sensibly transformed into a marketable product for the single scientist and for Göttingen University", says Dr. Hans-Joachim Conrad, Executive Board of Management and Administration of the Göttingen University School of Medicine. The two partners have now signed a cooperation agreement.

NEMESYS is an absolute novelty in its function and its applicability in neurology: NEMESYS runs as a client-server-application on a database. By digital connection to neurological derivation devices (e.g. EEG, EMG), it is possible for the first time to work on different networked workplaces. Moreover, NEMESYS simplifies and standardizes the findings documentation in the area of Clinical Neurophysiology. The new system provides finding modules for the essential neurodiagnostical examination proceedings like EEG, EMG, EP, transcranial magnet stimulation, doppler-/ duplex sonography and EEG monitoring.

NEMESYS was certified by the German Society for Clinical Neurophysiology and Functional Imaging (DGKN). The extent of documentation as well as structure and classification of the findings modules were developed in arrangement with the DGKN and geared at international documentation standards.

Professor Walter Paulus, Director of the Department of Clinical Neurophysiology at the UKG: "We are pleased to have found an innovative partner like the company MEDNOVO, who will not only market but also enhance NEMESYS."

MEDNOVO offers the system NEMESYS as an additional module for its product family MediColor, an imaging and findings documentation system in functional diagnostics. Michael Heinlein, Managing Director of MEDNOVO Medical Software Solutions GmbH: "With the acquisition of NEMESYS we can complement the content of our system MediColor very well. In the near future, we will offer MediColor-Nemesys not only in Germany but also internationally."

NEMESYS is already in use at the University Hospital of the Georg-August-University Göttingen, at the Hospital Bremen-East, and at the Hospital of the Johannes-Gutenberg-University Mainz.

About the Department of Clinical Neurophysiology at Göttingen University
The main emphasis of the research at the Department of Clinical Neurophysiology at Göttingen University is focused on the field of epilepsy and Morbus Parkinson as well as on the further development of the methods documented in NEMESYS. Moreover, an English NEMESYS version shall carry this documentation standard also to the Anglo-Saxon countries. For further information, please visit www.neurologie.uni-goettingen.de

About MBM Science Bridge GmbH
The MBM Science Bridge GmbH is the technology transfer organization of the University and operates as a mediator between inventors and industry partners. For further information, please visit www.sciencebridge.de

About MEDNOVO Medical Software Solutions GmbH
The MEDNOVO Medical Software Solutions GmbH is specialized in the de-velopment of medical documentation systems and the connection and integration of medical devices with various hospital information systems (HIS). For further information, please visit www.mednovo.de

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI, Health, and Health Care Today and To…

Artificial intelligence (AI) carries promise and uncertainty for clinicians, patients, and health systems. This JAMA Summit Report presents expert perspectives on the opportunities, risks, and challenges of AI in health...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

Improved Cough-Detection Tech can Help w…

Researchers have improved the ability of wearable health devices to accurately detect when a patient is coughing, making it easier to monitor chronic health conditions and predict health risks such...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...